Our Legacy
Pioneering the Convergence of Deep Tech and Human Vitality.

Our Strategic Roadmap
Founded with a vision of integrating deep tech into biotech, Vivarta Therapeutics has consistently innovated and expanded its offerings, establishing a strong foothold in the luxury skincare market.
Year 2026
Launch of Brahmé, Luxury Skincare.
Establishing high-spec 3rd-party manufacturing pipelines and securing DPIIT recognition under the Startup India initiative
Year 2027
Expansion into bioactive nutraceuticals.
Commencing pilot studies for proprietary ingredient extraction focused on skin longevity and metabolic health.
Year 2028+
Building upon our commercial success, Vivarta’s third phase is defined by the transition into high-scale biotechnological infrastructure. Our roadmap targets the establishment of proprietary research facilities and strategic alliances with leading global institutions. This evolution enables us to leverage our validated IP to provide specialized R&D and pharmaceutical-grade development services. Whether through our own advanced manufacturing or as a high-tier research partner, this phase solidifies Vivarta as a central pillar in the global life-sciences ecosystem.
Meet Our Team

Co-Founder and Chief Executive Officer (CEO)

Co-Founder and Chief Scientific Officer (CSO)

Head of Operations
